Illumina
Illumina is transforming human health as the global leader in sequencing and array-based technologies. Illumina's flexible and scalable sequencing systems support and enable a wide range of single-cell sequencing applications, from low-throughput deep interrogation of rare cell populations to high-throughput profiling of tissues. For more information, please visit www.illumina.com.
-
MAY 16, 2024 | 9:00 AM
The burden of antimicrobial resistance (AMR) has been acknowledged worldwide by leading healt• In this webinar Pietro Gatti, Associate Director & Future Tech Strategy Lead is joined... -
MAY 22, 2024 | 1:00 AM
Tuberculosis (TB) remains a leading global infectious disease killer, second only to COVID-191. It is an airborne disease caused by Mycobacterium tuberculosis bacteria and is responsible for...
-
APR 16, 2024 | 10:00 AM
The Comprehensive Genomic Profiling (CGP) ctDNA (circulating tumor DNA) panel generates complex biomarkers, e.g., tumor mutational burden and microsatellite stability status along with mutat...
-
MAR 21, 2024 | 10:00 AM
Next-generation sequencing (NGS) based liquid biopsy is emerging as standard of care in oncology for comprehensive genomic profiling (CGP) of solid tumors. In this presentation we will showc...
-
DEC 14, 2023 | 9:00 AM
Join our webinar where we will highlight key features of the NovaSeq™ X series including technology innovations, product updates, and features of the on-board DRAGEN™ secondary a...
-
SEP 27, 2023 | 9:00 AM
Join our webinar where we will highlight key NextSeq™ 1000 and 2000 product updates and features of the on-board DRAGEN Bio-IT platform. We will cover the basics of how the flexibility...
-
MAY 18, 2023 | 9:00 AM
Date: May 18, 2023 Time: 9:00am (PDT), 12:00pm (EDT), 6:00pm (CEST)...
-
March 23/24 2023C.E. CREDITS
Date: 24 March 2023...
-
APR 22, 2021 | 5:00 PM
Date: April 22, 2021 Time: 8:00am (PDT), 11:00am (EDT), 5:00pm (CEST) System transcriptomics of the schizophrenia brain - Phillip Khaitovich Schizophrenia tops the psychiatric disorder l...
-
APR 21, 2021 | 5:00 PM
Date: April 21, 2021 Time: 8:00am (PDT), 11:00am (EDT), 5:00pm (CEST) Spatial Answers Trilogy - Spatial Answers in Immunology Immunology Researchers share their Spatial Discoveries in SARS-C...
-
APR 20, 2021 | 5:00 PM
Date: April 20, 2021 Time: 8:00am (PDT), 11:00am (EDT), 5:00pm (CEST) Spatial Answers on Oncology - Professor Joan Seoane Prof. Joan Seoane, Group Leader and Director of the Translational Re...
-
NOV 16, 2020 | 8:00 AM
Date: November 16, 2020 Time: 8:00am (PST), 11:00am (EST) CRISPR screening has become the prime discovery tool in modern biomedical research and drug discovery. At the same time, most screen...
-
OCT 29, 2020 | 6:00 AM
Date: October 29, 2020 Time: 6:00am (PDT), 9:00am (EDT), Chronic inflammation can occur as a result of a combination of genetic predispositions and environmental factors. Epigenetic modifica...
-
SEP 02, 2020 | 7:00 AM
DATE: September 2, 2020 TIME: 03:00pm PDT, 6:00pm EDT Spatial omics is an expanding collection of methods to examine biological molecules in their geographical context. By retaining the prec...
-
SEP 17, 2019 | 9:00 AM
DATE: September 17, 2019TIME: 9:00am PTSpatial Transcriptomics (ST) technology reveals gene expression from up to one thousand spots across a tissue section. In this webinar, Dr. H...
-
SEP 11, 2019 | 9:00 AM
Learning objectives:1. Metagenomic analysis is already complex, and complicated further by incomplete and non-standardized databases of known organisms2. Fungi may have their own 'mic...
-
MAY 09, 2019 | 9:00 AM
The advent of precision medicine largely depends on the creation of precise and accurate predictive tools. While most late-onset diseases are moderately to highly heritable, using genetic inf...
-
APR 10, 2019 | 12:00 PM
Personalized medicine driven by genomic-based treatments continues to increase in importance. Representatives from two distinct healthcare entities – a regional reference lab and commun...
-
FEB 27, 2019 | 1:30 PM
NTRK fusions are rare but important recent biomarkers linked to response to new TRK inhibitors. Comprehensive genomic profiling on all solid tumors permits detection of rare genomic events an...
-
APR 30, 2024Immuno-Oncology Virtual Event Series 2024
-
MAY 07, 20243rd International Biosecurity Virtual Symposium
-
JUN 06, 2024The Future of Scientific Conferencing
- See More
-
MAY 07, 2024Is It Anti-RNP or Anti-Sm/RNP?
- See More
